Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clonidine-induced immune complex disease.

H H Petersen1, M Hansen, J M Albrectsen

  • 1Department of Rheumatology, Glostrup Hospital, Copenhagen, Denmark.

Acta Dermato-Venereologica
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sero-prevalence and risk factors of <i>Toxoplasma gondii</i> infection in wild cervids in Denmark.

International journal for parasitology. Parasites and wildlife·2022
Same author

Inactivation of Cryptosporidium parvum oocysts and faecal indicator bacteria in cattle slurry by addition of ammonia.

Journal of applied microbiology·2020
Same author

Morphological and molecular characterization of Cystoisospora laidlawi oocysts (Apicomplexa: Eimeriidae) in farmed American mink (Neovison vison) in Denmark.

Parasitology research·2020
Same author

Factor VIII with a 237 amino acid B-domain has an extended half-life in F8-knockout mice.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Morphological and molecular characterisation of Eimeria vison-like oocysts (Apicomplexa:Eimeriidae) in farmed mink (Neovison vison) in Denmark.

Parasitology research·2018
Same author

Echinococcus multilocularis in Denmark 2012-2015: high local prevalence in red foxes.

Parasitology research·2018
Same journal

A Facial Lesion with Cord-like Induration and Ring-like Appearance on MRI: A Quiz.

Acta dermato-venereologica·2026
Same journal

Real-world Outcomes of Adalimumab in Hidradenitis Suppurativa: A 10-year Retrospective Longitudinal Study.

Acta dermato-venereologica·2026
Same journal

An 8-year-old Girl with Multiple Whitish Dots on the Hair Shaft: A Quiz.

Acta dermato-venereologica·2026
Same journal

A Congenital Subcutaneous Tumour of the Scalp in a Child: A Quiz.

Acta dermato-venereologica·2026
Same journal

Commentary on: "The Effects of Sun Exposure and Pigmentation Phenotype on Prognosis in Metastatic Melanoma".

Acta dermato-venereologica·2026
Same journal

Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study.

Acta dermato-venereologica·2026
See all related articles

Clonidine treatment can trigger immune complex disease, characterized by antibody and complement deposits in tissues. Discontinuing clonidine therapy led to symptom resolution and normalized blood test results in a patient.

Area of Science:

  • Immunology
  • Nephrology
  • Rheumatology

Background:

  • Immune complex diseases involve deposition of antigen-antibody complexes, leading to tissue damage.
  • Clonidine, an antihypertensive medication, has been rarely associated with adverse immune reactions.

Observation:

  • A 46-year-old woman developed symptoms suggestive of immune complex disease after one year of clonidine treatment.
  • Histological examination revealed immunoglobulin G (IgG) and immunoglobulin M (IgM) complexes, along with complement components (C1q, C3c, C4) in muscle tissue and at dermo-epidermal junctions.

Findings:

  • The patient's clinical presentation and laboratory findings were consistent with drug-induced immune complex disease.
  • Cessation of clonidine therapy resulted in significant clinical improvement and normalization of blood test parameters.

Related Experiment Videos

Implications:

  • This case highlights a potential adverse effect of clonidine, emphasizing the importance of considering drug-induced etiology in immune complex disease.
  • Further investigation into the mechanisms of clonidine-induced immune responses may be warranted.
  • Clinicians should be vigilant for immune-related adverse events in patients treated with clonidine.